Clinical trials face increasing pressure to deliver new treatments to market faster. IQVIA Connected Devices accelerates trial outcomes with medical device recommendations that fit your clinical study, deliver cleaner data, and speed data collection and analysis with lower patient and site burdens.
Infographic
Continuous Glucose Monitoring
IQVIA's Continuous Glucose Monitoring offers a more complete view of the daily measures of glucose levels and variability than the traditional measures of glucose control by self-monitored blood glucose (SMBG) and HbA1c, promoting enhanced patient safety and clinical outcomes. Our innovative platform – combined with leading operational and therapeutic expertise – captures, cleans and analyzes glucose data, enabling meaningful compound differentiation. To learn more, download our infographic.
Related solutions
Connected Devices
Clinical Trials
Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.
Safety & Regulatory Compliance
Meet the challenge of changing stakeholder demands and increasing cost constraints with IQVIA's integrated technology services and analytics-driven offerings.
Clinical Research & Development Solutions
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
